tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALLO Stock Latest News

Allogene activates three cancer centers as first sites for Phase 2 ALPHA3 trial
The FlyAllogene activates three cancer centers as first sites for Phase 2 ALPHA3 trial
2d ago
ALLO
Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
PremiumPress Releases
Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL)
2d ago
ALLO
Allogene Therapeutics initiates Phase 2 cema-cel trial
PremiumThe Fly
Allogene Therapeutics initiates Phase 2 cema-cel trial
13d ago
ALLO
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
PremiumPress Releases
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
13d ago
ALLO
Allogene Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
Allogene Therapeutics participates in a conference call with JPMorgan
20d ago
ALLO
Allogene Therapeutics Enhances Leadership and Affirms Shareholder Decisions
PremiumCompany AnnouncementsAllogene Therapeutics Enhances Leadership and Affirms Shareholder Decisions
22d ago
8K
ALLO
Allogene Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Allogene Therapeutics initiated with an Overweight at Piper Sandler
1M ago
ALLO
Insiders Pour Millions Into These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Insiders Pour Millions Into These 2 ‘Strong Buy’ Stocks
1M ago
ALLO
FOUR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PFE
VIR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PFE
RNA
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
PremiumPress Releases
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
1M ago
ALLO
Insider Trading: Allogene Therapeutics’ Insider Buys Shares Worth $5M
PremiumMarket News
Insider Trading: Allogene Therapeutics’ Insider Buys Shares Worth $5M
1M ago
ALLO
Allogene Therapeutics price target lowered to $13 from $14 at Oppenheimer
PremiumThe FlyAllogene Therapeutics price target lowered to $13 from $14 at Oppenheimer
1M ago
ALLO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RNA
ABIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ACIU
ALLO
Allogene Therapeutics price target lowered to $9 from $10 at H.C. Wainwright
PremiumThe Fly
Allogene Therapeutics price target lowered to $9 from $10 at H.C. Wainwright
2M ago
ALLO
Allogene Therapeutics price target raised to $4.60 from $4.40 at Stifel
PremiumThe Fly
Allogene Therapeutics price target raised to $4.60 from $4.40 at Stifel
2M ago
ALLO
Allogene Therapeutics 37.93M share priced at $2.90
PremiumThe Fly
Allogene Therapeutics 37.93M share priced at $2.90
2M ago
ALLO
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
PremiumPress Releases
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
2M ago
ALLO
Allogene Therapeutics reports Q1 EPS (38c), consensus (41c)
PremiumThe FlyAllogene Therapeutics reports Q1 EPS (38c), consensus (41c)
2M ago
ALLO
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
PremiumPress Releases
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
2M ago
ALLO
ALLO Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ALLO Upcoming Earnings Report: What to Expect?
2M ago
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >